Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis

• Main Authors: Yunbao Xu (Author), Mengting Zhang (Author), Jiaying Zhang (Author), Derry Minyao Ng (Author), Xiaoxiao Chen (Author), Yuexiu Si (Author), Yetan Shi (Author), Xiangyuan Li (Author), Danyi Mao (Author), Lu Yang (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cervical cancer is a global health challenge in women. Neoadjuvant chemotherapy (NACT) is a recent prospect for alternative cervical cancer treatments. This study investigated the efficacy of NACT against resectable cervical cancer based on the medium and long-term survival of patients with the dise...